A Study of the Absorption, Metabolism, and Excretion of GBT440 in Healthy Male Subjects

Completed · Phase 1

Conditions studied: Anemia, Sickle Cell

In brief

This study will provide information regarding the metabolic pathway of GBT440, the need for evaluation of potential drug-drug interactions, and the need for studies in special populations. The administration of radiolabeled drug is necessary to fully characterize the rates and routes of elimination of GBT440, providing further quantitative information on the disposition of GBT440. The results from this study will permit a comprehensive comparison between animal and human routes of elimination and metabolic profiles of GBT440.

Key facts

Study ID
NCT02497924
Run by
Global Blood Therapeutics
People needed
7
Starts
2015-06-01
Expected to finish
2016-07-01
Last updated by the study team
2017-04-12

Who can join

Age: 18 and older, up to 55. Sex: male. Healthy volunteers: accepted.

You may qualify if…

You may not qualify if…

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.